The intelligent system takes highly integrated engineering technology as the core

Has reached in-depth cooperation with Xinbang Intelligent Equipment and successfully introduced its self-developed multi-robot collaborative automation system to fully realize the intelligent upgrade of the production process of varicella and other active vaccines. This technological innovation marks a key step in the transformation of enterprises from traditional manual operation to fully automated and digital manufacturing in the key links of biopharmaceuticals. The intelligent system takes highly integrated engineering technology as the core, and upgrades the complex processes such as cell culture, liquid treatment and material transfer, which originally relied on manual work, into a fully closed and fully automatic intelligent operation system. The whole production line is equipped with 12 aseptic six-axis industrial robots, which have excellent motion accuracy and efficient coordination ability. They can accurately complete many core process operations such as automatic loading and unloading of multi-layer cell factories, constant force shaking culture and high-throughput liquid filling. All processes are carried out in an isolator that meets the requirements of A- level clean environment, which completely realizes the physical isolation between personnel and the production area, effectively eliminates the risk of pollution caused by human intervention, and significantly reduces the hidden dangers of cross-contamination and biosafety exposure. The entire production process is designed in strict accordance with GMP specifications, through standardized program control, real-time data collection and traceable management of the whole process to ensure the quality consistency and stability of each batch of products. Thanks to the efficient operation of the system, the company's annual production capacity has achieved a leap-forward increase, steadily breaking through millions of doses, which not only meets the growing market demand, but also provides a replicable technical path for subsequent expansion of production scale. What is particularly noteworthy is that the successful application of the system has filled a number of technical gaps in the field of automatic production of high-end biological agents in China. it provides a practical solution for the large-scale and high-quality mass production of active vaccines and other biological drugs that require extremely high aseptic conditions. This is not only an important milestone for vaccine manufacturing to move towards intelligent manufacturing, but also fully demonstrates the technical strength of domestic intelligent equipment in precision control, aseptic operation and system integration. This cooperation has set a benchmark for the digital transformation and upgrading of the biomedical industry, and promoted the continuous progress of the industrial chain towards high-end and intelligent direction. In the future, with the integration and application of more innovative technologies, Xinbang intelligent equipment will continue to help pharmaceutical companies build a safer, more efficient and smarter production system, and inject strong momentum into the high-quality development of China's biomedical industry.